The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
Efsun SomayErkan TopkanUmur Anıl PehlivanBusra YilmazAli Ayberk BesenHuseyin MertsoyluBerrin PehlivanUgur SelekPublished in: Tomography (Ann Arbor, Mich.) (2024)
The presence of a smaller pretreatment TMMV is a reliable and independent novel biological marker that can confidently predict higher RIT rates in LA-NPC patients who receive C-CRT.
Keyphrases
- radiation induced
- locally advanced
- rectal cancer
- end stage renal disease
- radiation therapy
- squamous cell carcinoma
- ejection fraction
- newly diagnosed
- chronic kidney disease
- neoadjuvant chemotherapy
- prognostic factors
- peritoneal dialysis
- heart failure
- phase ii study
- lymph node
- patient reported outcomes
- patient reported
- study protocol